Abstract:

Namibia has an adult HIV prevalence of 12.6% according to the Namibia population-based HIV impact assessment survey of 2017 making it one of the highest in the world. Early initiation of antiretroviral therapy (ART) has excellent outcomes for both morbidity and mortality. The National Strategic Framework for HIV and the Namibia Ministry of Health and Social Services (MoHSS) rolled out the WHO 2015 UTTS guidelines making Namibia one of the first African countries to implement UTTS. With UTTS guidelines, rolled out in October 2016, clients who test HIV positive are initiated on ART immediately preferably the same day or within seven days regardless of their HIV clinical stage or CD4 count. Retention in care is required for optimal clinical outcomes in patients with HIV infection. However, after two years of adopting the strategy, it is not well understood whether UTTS affects the retention to care. We therefore sought to establish any emerging differences in retention of ART care after the implementation of UTTS. We used a retrospective cohort review study design that employed both quantitative and qualitative methods. 879 client records were reviewed, 678 clients were initiated on treatment two years prior to the UTTS and 201 were initiated after January 2017 when the UTTS was fully rolled out and had been on treatment for at least 12 months. Data analysis was done using Excel and Statistical Package for Social Sciences (SPSS) version 23.0 software. The overall retention after 12 months of follow-up was (822/879) 93.5% (95% CI: 91.3% to 95.7%). The retention rate at 12 months among clients in the UTTS cohort was 95.5% (95% CI: 93.5% to 97.5%) and somewhat higher than that in the pre-UTTS cohort 92.9% (95% CI: 90.6% to 95.2%). At the end of the review period, attrition was higher in the pre-UTTS cohort 251/678 (37.0%; 95% CI 34.8 to 39.2) versus 42/201 (21.0%; 95% CI 19.0 to 23) during UTTS. Retention on ART was nearly 5% higher after UTTS implementation but young adults and men between 31 and 40 years of age had higher chances of attrition at the time of ART initiation. We recommend that all facilities in Namibia and other parts of sub-Saharan Africa should embrace the UTTS strategy to benefit their clients.

References:

[1] Namibia Population-Based HIV Impact Assessment, 2016-2017 https://phia.icap.columbia.edu/wp/content/uploads/2018/10/NAMPHIA-pdf.

[2] Namibia National Guideline for Antiretroviral Therapy 2016: https://aidsfree.usaid.gov/sites/default/files/na_national_guidelines_art.Pdf.

[3] World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2018: http://apps.who.int/iris/bitstream/10665/208825/1/.

[4] Temprano ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N England J Med. 2015.

[5] Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1 –infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010; 50(10):1387–96.

[6] Insight Start Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015; 373(9):795–807.

[7] Messeri PA, Abramson DM, Aidala AA, et al. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care. 2002; 14(Suppl 1): S15–S29.

[8] Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009; 23(1):41–9.

[9] Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009; 48(2):248–56.

[10] Alhaj Mohammad, Amberbir Alemayehu, Singogo Emmanuel Banda Victor, Lettow Monique, Matengeni, Alfred (2019) et al. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study. Journal of the International AIDS Society. 22. e25239. 10.1002/jia2.25239.

[11] McCreesh N, Andrianakis I, Nsubuga RN, Strong M, Vernon I, McKinley TJ, et al. Universal test, treat, and keep improving ART retention is key in cost effective HIV control in Uganda. BMC Infect Dis. 2017; 17(1):322.

[12] Brown LB, Havlir DV, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, High levels of retention in care with streamlined care and Universal Test and Treat in East Africa. AIDS. 2016; 30(18):2855–64.

[13] Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by ‘test and treat’ in hyper-endemic settings. AIDS. 2010;24(5):729.

[14] Bigna JJ, Plottel CS, Koulla-Shiro S. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count. Infect Dis Poverty. 2016;5(1):85.

[15] Hayes R, Sabapathy K, Fidler S. Universal testing, and treatment as an HIV prevention strategy: research questions and methods. Curr HIV Res. 2011;9 (6):429–45.

[16] Brown LB, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, et al. Predictors of retention in HIV care among youth (15–24) in a Universal Test-and-Treat setting in Rural Kenya. J Acquir Immune Defic Syndr. 2017;76 (1): e15–8.

[17] Wolf HT, Halpern-Felsher BL, Bukusi EA, Agot KE, Cohen CR, Auerswald CL. “It is all about the fear of being discriminated [against]. . . the person suffering from HIV will not be accepted”: a qualitative study exploring the reasons for loss to follow-up among HIV-positive youth in Kisumu, Kenya. BMC Public Health. 2014; 14:1154.

[18] MacKenzie RK, Lettow M, Gondwe C, Nyirongo J, Singano V, Banda V, et al. Greater retention in care among adolescents on antiretroviral treatment accessing “Teen Club” an adolescent-centred differentiated care model compared with standard of care: a nested case–control study at a tertiary referral hospital in Malawi. J Int AIDS Soc. 2017;20(3): e25028.

[19] Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng’ambi W, Bokosi M, et al. Understanding factors, outcomes, and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360–6.

[20] Chan AK, Kanike E, Bedell R, Mayuni I, Manyera R, Mlotha W, et al. Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi. J Int AIDS Soc. 2016;19(1):20672.

[21] Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). J Int AIDS Soc. 2014;17(1):18994.

[22] Jasseron C, Mandelbrot L, Dollfus C, Trocm e N, Tubiana R, Teglas JP, et al. non-disclosure of a pregnant woman’s HIV status to her partner is associated with non-optimal prevention of mother-to-child transmission. AIDS Behav. 2013; 17(2):488–97.